New Developments in the ISN

Issue • 2003

an official publication of the
international society of nephrology


New Developments in the ISN


The ISN is undergoing rapid change—change that is
necessary to enable the ISN to continue expanding its programs in the pursuit
of its overarching goal to enhance nephrology worldwide.

Having realized the need to
centralize and professionalize our management—to improve funding and
become more effective—the Executive and Council requested proposals from
Association Management Companies across both the USA and Europe. A rigorous
selection process resulted in our appointing GIC Management in Brussels,
Belgium to head up our new global headquarters, effective April 1, 2003.

We have also embarked on
fund-raising endeavors. This is in part a promotional and awareness drive, as
well as an attempt to attract more funds to our Society to underwrite and
expand our programs.

Another initiative has been
the formation of partnerships. We cannot do everything alone and we have tried
to expand our partnerships, particularly in educational activities, with our
affiliated national societies (we have over 90) and with regional nephrological
societies. An example is our Berlin Congress in June 2003, in which we will
combine with the European Renal Association and another four nephrology
societies. ISN-COMGAN successfully partnered with 35 local nephrology societies
to deliver educational programs to over 11,000 physicians last year alone.

We are also forming
partnerships with societies in other disciplines. We have formed a liaison
committee with the International Diabetes Federation in an attempt to combat
the world pandemic of diabetic nephropathy, the major cause of end stage renal
failure worldwide. Indeed, the number of diabetics will double in the next 15
years; 80% of the increase will be in emerging countries. The IDF and ISN have
already combined in a submission to the World Bank, to produce a book on
Diabetes and the Kidney, and to hold a joint conference prior to the Berlin
Congress. 2003 has been designated the year of the Diabetic Kidney.

Prevention of renal disease
is an important aspect of nephrology, particularly in emerging countries. The
ISN-COMGAN Research Committee has been developing ways of implementing
screening and prevention programs with local and national societies, aid
agencies, government and international bodies.

The ISN is now moving into a
very exciting time in its development. We would like to attract new members to
help us pursue our goal of continuously improving nephrology globally. Every
nephrologist has dual duties: to treat optimally his or her patients, and to
help promote nephrology to the public, to governments and to other

I call on all our members to
help the nephrological cause. Any suggestions, concerns, criticisms or opinions
can be put to your Executive and Council and your input will be much

The ISN is a Society of
individual nephrologists and scientists with an interest in kidney disease. Our
Society needs to continue evolving to cope with the challenges we face and to
ensure our patients with kidney disease receive the best treatment and care
that we can offer.




From the Editor


These are exciting times and this is reflected in this issue
of ISN News. One of the most important decisions ever taken by ISN was to
identify the development of nephrological practice across the world as one of
its major goals. The result has been a spectacular success: quite simply
ISN-COMGAN is unique and no other International medical societies have a
comparable organization; the ISN Fellowship program has been similarly
successful. These achievements bring further challenges, most notably the need
for ever larger amounts of money to expand and further develop these programs.
These challenges are at the heart of the developments described by ISN
President Bob Atkins in his message to us.

The prescience of the
decisions to establish ISN-COMGAN and the ISN Fellowships is a testament to the
wisdom of the past ISN leadership and we will need similar wisdom if we are to
get things right in the future. This emphasizes the importance of this
year’s election of nine new ISN Councillors. The brief biographies of those
nominated for these positions demonstrate a wealth of talent and experience. It
is vital that all members vote in the election to give the successful
candidates the strongest possible mandate.

Finally, in regard to the
World Congress in Berlin this June. It was a tragedy that the 2001 World
Congress in San Francisco was held in the shadow of the terrible events of 11
September. Despite this, it was a triumph and the program for Berlin looks just
as exciting. So join us there to work, learn and play. Certainly, it will be a
celebration of all that is good and exciting in nephrology.



Baxter and ISN Announce First Round
of Renal Discoveries Grant Program Winners


The Renal Discoveries extramural grant program developed by
Baxter Healthcare Corporation in collaboration with the International Society
of Nephrology (ISN) is designed to promote scientific understanding of kidney
disease and to advance its treatment. The program continues Baxter’s
support of the study of kidney disease, including pathophysiology and treatment
options, by building on a previous grant program that distributed more than $25
million to 221 grant winners in 20 countries. It provides much needed resources
to enable scientific researchers to pursue broad, long-term basic and applied
studies. Such studies are critical to enhancing the collective knowledge base
on kidney disease and treatment.

The first round of the Renal
Discoveries program was on the topic of Inflammation and Kidney Disease and
attracted 96 proposals for basic or applied research from 21 countries.
Proposals were judged strictly on scientific merit by an independent medical
advisory board consisting of ISN members; membership of the board will rotate
to ensure breadth of scientific judgment. At the end of July, the board
selected 10 outstanding proposals from seven different countries and awarded up
to US $50,000 per year for three years for the basic clinical research and up
to US $75,000 per year for the three year applied research. Those granted
applied clinical research awards are eligible to apply for increased funding up
to US $300,000 in years two and three.

Lee W. Henderson, MD, FACP,
the Extramural Grant Program founder, said, “I congratulate the ten grant
winners on their outstanding science, which will contribute significantly to
the advancement and knowledge of kidney disease and its clinical applicability.
Our hope and our goal is that the patient becomes the ultimate winner.”
ISN President Bob Atkins said, “The ISN strongly encourages scientists
from across the globe to apply for a grant from the Renal Discoveries program.
By applying for a grant, a scientist is helping to expand knowledge about kidney
disease and its treatment—a contribution that enriches lives and

Renal Discoveries is modeled
after grant programs managed by the United States National Institutes of
Health, with topics announced twice each year, and detailed writing
instructions to guide applicants through the process. An independent medical
advisory board evaluates applications based on scientific merit. Requests for
proposals for the program’s Round 2 topic, Cardiovascular Morbidity and
Mortality in Kidney Disease, have been distributed worldwide and are currently
being considered. For more details go and

Grants Awarded

1  Laurent Baud, MD, PhD, INSERM, Paris,
France, “Proteases Involved in the Activation of Latent Transforming
Growth Factor-b (TGF-b) Play a Role in the Development of Renal

2  Giacomo Garibotto, M.D., University of
Genoa, Genoa, Italy. “Effects of Low-grade Chronic Inflammation on Muscle
Protein Turnover in Patients with End-stage Renal Disease.”

3  Enyu Imai, M.D., Ph.D., Osaka University
Graduate School of Medicine, Osaka, Japan. “Proteinuria Induced
Inflammatory Reaction in Proximal Tubule.”

4  Hui Yao Lan, MD, PhD, Baylor College of
Medicine, Houston, Texas. “Role of Smad Signaling in the Pathogenesis of
Hypertensive Nephropathy and A Novel Therapeutic Potential Using
Ultrasound-Microbubble Gene Transfer of Inducible Smad7.”

5  Christopher Y. Lu, MD, Univ. Texas
Southwestern Medical Center at Dallas, Dallas, Texas. “RAE 1, NKG2D, and
Innate Leukocytes in Ischemic Acute Renal Failure.”

6  Robert H. Mak, M.D., Ph.D., Oregon Health
& Science University, Portland, Oregon. “Cytokine Signaling and
Cachexia in Uremia.”

7  Andreas Pierratos, MD, Humber River
Regional Hospital, Toronto, Ontario, Canada. “Impact of Nocturnal Hemodialysis
on the Malnutrition—Inflammation—Atherosclerosis Axis.”

8  Gregory H. Tesch, BAppp, Sc, MSc, PhD,
Monash Medical Centre, Clayton, Victoria, Australia. “Stress Activated
Protein Kinase Signaling: a Key Pathway for Both Inflammation and Fibrosis in
Peritoneal Membrane Dysfunction?”

9  David C. Wheeler, MB, ChB, MD, Royal Free
and University College Medical School, London, England, United Kingdom.
“Molecular Mechanisms and Consequences of LDL Receptor Dysregulaion by
Inflammatory Cytokines.”

10        Veronique
Witko-Sarsat, PhD, INSERM, Paris, France. “Role of Myeloperoxidase and
its Derivatives, the Advanced Oxidation Protein Products (AOPP), in Chronic
Renal Failure.” isn


Renal Discoveries is a trademark of Baxter International Inc.



Secretary General’s Report

New Global Headquarter for ISN

During a 3-day retreat in Chicago Airport Hilton, the ISN
Executive moved to hire a professional management company to take over the
administrative duties of the secretariat, finance, and ISN-COMGAN offices under
one roof. To this end, the Executive solicited proposals from fifteen
Association Management Companies (AMC), resulting in the selection of GIC
Management, Europe’s leading independent AMC. As of 1 April, 2003 the new
global headquarters and professional staff of ISN will reside in the offices of
GIC Management in Brussels, Belgium. Centralizing our management and operations
will result in greater efficiency and streamlined communications, thus allowing
the executive officers, no matter where they are located, to focus fully on
strategic developments for the society and nephrology. The newly appointed
management company will also be responsible for fund raising, organizing ISN
meeting and congresses, and the public promotion of the ISN image. More
information about the transition of administrative activities to the new global
headquarters in Brussels will be posted at

New Affiliated Society

The application from the Venezuelan Society of Nephrology to
affiliate with the ISN was approved by the Executive Committee, pending
ratification by the General Assembly in Berlin. This shall be the 69th national
society to join forces with ISN.

Fellowship Program Flourishes

So far, over 300 fellows from 62 countries have received
clinical, technical or basic research training in 17 countries under the
umbrella of the ISN Fellowship Program. The annual budget is close to US$
750,000, two thirds of which is provided by ISN, with the rest provided by the
American and Japanese Societies of Nephrology, the National Kidney Research
Fund of Great Britain, The European Renal Association, The Sheffield Kidney
Institute of the United Kingdom, and Fresenius Medical.

Information on past and
present fellows is now kept in a Web-based central database accessible to the
five ISN offices that are engaged with this program (Secretary-General’s,
Treasurer’s, Editorial, COMGAN offices, and the Secretariat). This
important technical achievement is expected to significantly improve the
integration of fellows’ services, their privileges and administrative

Fellows’ Work Blossoming

As was the case in San Francisco, a special arrangement has
been made to highlight the outcome of fellows training and scientific impact on
their home countries. All fellows’ posters shall be displayed twice: in
the “general” halls by category, as well as in the special ISN
poster zone. There will be a separate Fellows’ poster-viewing session to
which senior members of the international renal community will be invited. A
committee comprised of Professors Schrier, Cameron, and Becker shall select the
4 best posters. These shall be sign-posted and subsequently presented in a
special oral session. The poster authors will receive medals and checques,
kindly donated by the Japanese Society of Nephrology.

Travel Grants for Berlin

Young investigators and ISN past and present fellows were
invited to apply for travel grants for the Second World Congress of Nephrology
in Berlin. ISN is providing 120 grants, ERA 60 grants and the European Society
of Pediatric Nephrology 30 grants. Winners of these grants who are based in
Europe shall receive ?500, whilst
those based elsewhere in the world shall receive ?1000.

ISN Website’s new look

The ISN Website is being upgraded for style, content and
technology. An Editorial Board has been appointed, with 4 Section Editors
(Public, Membership, Council, Offices staff) who will keep their respective
sections of the website adequately targeted, informative and up-to-date. Kidney
International will be linked directly to the Membership section, and the
Newsletter will be linked to the Public section. The site will be based on
Flash technology, which allows for fast browsing and more attractive multimedia
presentations. Adequate measures shall be implemented to secure the different
sections in accordance with their targets and content. isn



The World Congress of Nephrology
2003, Berlin


The World Congress of Nephrology will be the meeting to go
to this year. It takes place between 8 and 12 June at the International
Congress Centre, Berlin. It has been organized jointly by the ERA/EDTA and the
ISN, in cooperation with the European Society for Pediatric Nephrology (ESPN),
the European Kidney Research Association (EKRA), the Gesellschaft für
Nephrologie and the Deutsche Arbeitsgemeinschaft für Klinische

The program committee,
chaired by Heini Murer, has devised an extraordinarily attractive program,
which has something for everyone. The emphasis is on the new and the
controversial, with a strong element of continuous nephrological education. A broad range of issues at the forefront of basic
and clinical nephrology will be addressed in state of the art lectures,
symposia, clinical nephrology conferences, clinical nephrology controversies,
mini-lectures, free communications and posters. There will also be a special
session for ISN Fellows to present their work. ISN Fellows will be awarded prizes
for the best posters.

 Ten main lectures will cover topics that range from basic
science to clinical investigation and therapeutic strategies. The lecturers
are: G. Blobel, M. Goldman, T. Jentsch, F. Luft, R. MacKinnon, J. Remuzzi, G.
Schatz, D. Schlöndorff, K. Tryggvarson, and R.A. Winston. Details of their
talks may be found on the congress website. Of particular note in the science
arena will be the lectures on protein targeting within the cell, to be given by
the 1999 Nobel Laureate in Medicine, Gunter Blobel, and the talk on embryonic
stem cells, to be given by Robert Winston, which will cover ethical and legal
questions as well as biology. In the clinical area, Giuseppe Remuzzi will
discuss the most important issue facing nephrologists worldwide: How to reduce
the need for dialysis, by using other therapeutic interventions.

There will be a huge variety
of clinical nephrology symposia on different aspects of dialysis,
transplantation, and general nephrology. There will also be a series of
pediatric nephrology symposia organized by the ESPN; and symposia that address
issues at the interface between pediatric and adult nephrology. Clinically
oriented sessions will be complemented by nine basic science symposia, and
symposia on rehabilitation and nephrology in the emerging world, which will be
run by specialty groups.

There will be a series of
clinical nephrology conferences, with five covering adult topics and four
covering pediatric topics. Adult nephrology topics include the selection of
anti-hypertensive agents for patients with renal disease and the kidney in
pregnancy, whilst those for pediatric nephrologists include peritoneal dialysis
and glomerulonephritis. Other sessions will cover controversies. In addition,
five separate Continuous Nephrological Education (CNE) programs, in English,
Spanish, French, Polish and German, have been organized by the national

There is also a fabulous
social program starting June 8, with the opening ceremony in the International
Congress Centre. This will include a lecture by G. Schatz entitled “What
our genome does not tell us” and a buffet dinner. Later on there will be
a congress concert by the Berlin Philharmonic Orchestra, and an evening at the
world famous Berlin Museums. The Congress will be preceded by an ISN Forefront
in Nephrology Symposium “Immunology in Renal Diseases,” and
“Diabetes and the Kidney,” a symposium jointly organized by the ISN
and the International Diabetes Foundation. There will be nine post-congress satellites,
and a specific scholarship training course for young Eastern European
nephrologists, jointly sponsored and organized by the ISN and the ERA.

Details of all the congress
events and of how to register can be found on the Congress website
( The website also gives information about hotel
accommodations, and about Berlin more generally.

Dr. Eberhard Ritz is the Congress President for the 2003 World
Congress of Nephrology



Nominations for ISN Council 2003-2009


Eight Councilors will end their terms by June 2003: Anthony
Clarkson (Australia); Visith Sitprija (Thailand); Hideto Sakai (Japan); Carl
Mogensen (Denmark); Claudio Ponticelli (Italy); Andrew Rees (UK); Eberhard Ritz
(Germany) and Josephine Briggs (United States). In addition, there is a ninth
vacancy created by the election of Councilor William Couser (United States) as
vice president, which is being temporarily filled by the appointment of Amin
Aranout (United States), who was the first runner-up for North America in the
2001 elections (in accordance with Article III, Section 6 of the ISN

The procedure for filling
these vacancies includes three steps (Article V, Section 2
). First, the Nominating Committee is to propose three
names per vacancy. Second, the proposed list is to be reduced to two candidates
per vacancy through a Council ballot. Finally, the membership is to select one
candidate for each vacancy through a general ballot.

The first two steps in this
process were completed in Philadelphia on November 5, 2002. There are now 18
candidates to fill the nine vacancies. The names, photographs, and brief
biographies are being published in Kidney International
, ISN News and the ISN Web site. All members of the Society
except the Corporate are invited and encouraged to vote. Eligible voters should
have a valid “Voting Identification Number (VIN)” that is printed
above the name in the address label of Kidney International
. VINs can also be obtained by phone (++ 31 20 566
4939) or e-mail ([email protected]
from the ISN Secretariat.

Voting can be accomplished
on-line, by mail, by fax, or by voting on-site during the World Congress of
Nephrology in Berlin in June 2003. For on-line voting, please visit the ISN Website
) and follow
the instructions. You will be prompted to enter your ID and VIN before the
ballot sheet is displayed. Once you have submitted your vote, your VIN will be
blocked and you will no longer be able to access this page. For voting by mail
or fax, please complete the ballot sheet that is printed on the back of the
address insert accompanying the March issue of Kidney International
and submit it by mail to Ilja Huang, Pathology
Department, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The
Netherlands, or by fax (++ 31 20 696 0389). Double voting (e.g., via the Web
site and by mail or fax) will cancel both votes. If you prefer to vote on-site
in Berlin, please visit the ISN booth on the first day of the Congress, where
only eligible members whose VINs are still “open” will be allowed
to vote.

Votes will be counted on
Monday, June 9, 2003, and the results will be announced the next day.

Rashad Barsoum is Secretary-General of the ISN.

Brief Biographies of ISN Council Nominees 2003-2009


M. Amin

Dr. Arnaout is Professor of Medicine at Harvard Medical
School and Chief of Nephrology at the Massachusetts General Hospital. He serves
on several boards, including the editorial board of the Journal of Clinical
and the scientific advisory
board of Keystone Research Symposia. He served as program chairman of Renal
Week 1998 and was chairman of the Basic Science Committee of the ASN from 1998
to 2001. He received the Presidential Medal of Excellence from the ASN in 2001.
He has major research interests in the fields of cell adhesion and molecular
nephrology, with a principal focus on the biology and structure of integrins
and the molecular and cell biology of polycystic kidney disease. He is the author
of over 130 original publications, a contributor to 34 books, and is currently
a co-opted member of the ISN council.

Miriam Bargman

Dr. Bargman is a graduate of the University of Toronto. Her
early training was in Toronto, Melbourne, and at Stanford University, but since
1983 she has worked in Toronto. Beginning in 1990 she has been a member of the
Executive Committee, Division of Nephrology, at the Toronto Hospital. A member
of many national and international societies, on the editorial board of Peritoneal
Dialysis International
and reviewer for
many journals, she has presented and published widely with more than 80 invited
presentations, 80 published papers, and 60 abstracts. Her main research
interests are peritoneal dialysis, glomerulonephritis, anemia of chronic renal
failure, and the social aspects of chronic renal disease.

Martin Moe

Dr. Moe graduated from the University of Illinois, College
of Medicine in Chicago, and after early postgraduate work in Chicago during
which she trained in nephrology, she moved to the Indiana University School of
Medicine where she is an Associate Professor of Medicine and Assistant Dean for
Research Support. She is also Chief of Nephrology at Wishard Memorial Hospital.
She is on several committees of the ASN and National Kidney Foundation and has
lectured and written extensively on calcium/phosphate status in renal failure
and renal bone disease, which are her main research interests. She has been
active academically and has published more than 100 articles, book chapters,
and abstracts.

(Suthan) Suthanthiran

Dr. Suthanthiran graduated from the University of Madras in
India. After an internship in Detroit, he became a Fellow in Nephrology at
Peter Brent Brigham Hospital in Boston before moving to Cornell University in
New York. He has been Professor of Medicine and Biochemistry at Cornell
University since 1989. He is currently the Stanton Griffis Distinguished
Professor of Medicine and Chief of Nephrology and Department of Transplantation
and Extracorporeal Therapy at New York Presbyterian Hospital. He has been
president of the American Society of Transplant Physicians and is a member of
many societies, including the American Society of Clinical Investigation and
the American Association of Physicians. He has received many grants and awards
for his work in transplantation medicine. He has published over 210 articles
and reviews on a wide variety of nephrology topics but his main interest is
transplantation medicine.


P. Gueco

Dr. Gueco graduated from the University of the Philippines
in Manila and did her initial postgraduate training in Manila. Her first
Fellowship in Nephrology was at the Kidney Center of the Philippines. She then
joined Addenbrooke’s Hospital, Cambridge in the United Kingdom, as a
Renal Fellow. Since 1996, she has been Assistant Professor at the University of
Philippines College of Medicine and is currently the Head of the Renal Section
of Philippines General Hospital, Head of the Renal Section and Dialysis Unit, The
Medical City, Mandaluyong City. She is a member of the Philippine
Transplantation Society, ASN, ISN, and has been treasurer, secretary, vice
president and president of the Philippine Society of Nephrology. She is
interested in particular in dialysis and transplantation and, as she has a
Masters Degree in Business Administration, Dr. Gueco is concerned with the
administration of renal services.

Charles Harris

Dr. Harris is Director of Dialysis in Western Sydney and is
a renal physician at Westmead Hospital in Sydney, Australia. He is Associate
Professor of Medicine at the University of Sydney. His early postgraduate years
were spent at Royal North Shore and Westmead Hospitals in Sydney, and as a
Research Fellow at University of Colorado Health Sciences Center in Denver,
Colorado. Dr. Harris is currently president of the Australian and New Zealand
Society of Nephrology, a member of ISN, ASN and a councilor of APSN. He has
been instrumental in developing ties between Australian and Indonesian
nephrologists and was chairman of the Scientific Program Committee from the
XIVth International Congress of Nephrology in Sydney in 1997, a position he
will also hold for the 18th ICN in Singapore in 2005. He has authored over 100
articles and reviews and over 150 abstracts mainly in the areas of progression
of renal failure, and dialysis.


Dr. Ichikawa graduated from Keio University, Tokyo Japan,
and did his residency in Pediatrics at Kitasato University Hospital. After 1
year in San Francisco, he travelled to Peter Brent Brigham Hospital in Boston
as a Fellow in Medicine. He remained at Harvard until he was appointed
Professor of Pediatrics at Vanderbilt University in Nashville, Tennessee, in
1985, where he is now Professor of Medicine. In 1998, he was appointed
Professor of Pediatrics at Tokai University, Tokyo, and is Associate Dean at
Tokai University. He is a member of many learned societies, has reviewed
articles for over a dozen journals, and has authored over 125 papers.


Dr. Prodjosudjadi is Professor of Internal Medicine, Medical
Faculty, University of Indonesia. He graduated from the University of
Indonesia, undertook postgraduate training in Tokyo, Sydney, and Leiden (The
Netherlands), developing interests in nephropathology, transplantation,
inflammatory renal diseases, and medical education. He was secretary general of
the Indonesian Society of Nephrology before becoming its president in 1999 and
is a councillor of APSN. He is particularly interested in the development of nephrology
in Indonesia and is a committee member of CREED program (Cross Regional
Education and Exchange in Dialysis). He has published many papers in national
journals and with his Dutch colleagues in international journals.

Wong Kok

Dr. Seng is currently Head and Senior Consultant, Department
of Renal Medicine at Singapore General Hospital. He is also Medical Director
and Chairman, Medical Board of the National Kidney Foundation of Singapore.
After graduating from the National University of Singapore, his postgraduate
training was in the Department of Renal Medicine in Singapore General Hospital
where he became a Consultant in 1993. He is currently a council member of APSN,
secretary of the Singapore Society of Nephrology, and council member of the Singapore
Society of Hypertension. His research interests are in hypertension, renal
failure, nephrotic syndrome, and renal transplantation.

Hai Yan Wang

Dr. Wang graduated from Beijing Medical University and after
3 years of internship, she became a Nephrology Fellow at First Hospital Beijing
Medical University until 1966. After a “time-out” during the
cultural revolution, she returned to practice and from 1980 to 1983 was
Visiting Scholar to the Division of Nephrology at the Harbor–UCLA Medical
Center in Los Angeles. Since 1983, she has been Chief of Nephrology and, in
1986, she became Professor of the Department of Medicine at the First Hospital
Beijing. Since 1995, she has been Chairman, Department of Medicine, Beijing
Medical University. She has been chairman of the Chinese Society of Nephrology
and currently is vice president of the Chinese Medical Association. A member of
the editorial boards of Chinese and international renal journals, she is a
member of ISN, ASN, and APSN, of which she is a councillor. She has published
over 200 articles and books in Chinese and English.


Tilman B.

Dr. Drüeke attended medical schools in Frankfurt,
Paris, and Tubingen. After 2 years internship in Cologne, he moved to Paris in
1969 and trained in nephrology at the Necker Hospital where he has worked until
the present time. In 1977, he became Associate Professor at the Medical School,
Necker–Enfants Malades, and in 1986, he became the Director of INSERM
Research Unit 90 until 1998, when he was appointed Director of INSERM Research
Unit 507. He is Editor-in-Chief of Nephrology, Dialysis and Transplantation,
the official journal of ERA-EDTA, a position he has held since 1999. His
scientific interest is specifically devoted to chronic renal failure, dialysis,
and arterial hypertension. He has published more than 300 articles in
peer-reviewed journals, is a member of seven professional societies, and serves
on the editorial board of six medical journals.


Dr. Feehally is currently Professor of Renal Medicine,
University of Leicester and Head of the Academic Division of Nephrology,
Leicester Warwick Medical School in the United Kingdom. He graduated from
University of London and has held tenured clinical and academic posts in
nephrology since 1988. He has established a research profile, especially in the
study of the pathogenesis of IgA nephropathy. He has held senior hospital
administrative positions but withdrew from these to commit more time to
nephrology locally, nationally, and internationally. He is treasurer of the
Renal Association (UK) and a member of ISN, ASN, British Transplantation
Society and ERA. He has published over 100 papers, book chapters and reviews
and is Editor of the book “Comprehensive Clinical Nephrology.”


Dr. Floege graduated from Hannover Medical School in
Germany. After an internship at Han­nover, he undertook research in the
Division of Molecular Pharmacology before undertaking training in nephrology
and later research in the Division of Nephrology and Department of Pathology at
the University of Washington in Seattle. In 1993, he was appointed Assistant
Professor, Division of Nephrology at the Hannover Medical School and was
promoted to Associate Professor in 1997. In 1999, he became Head of Nephrology
& Immunology at the University of Aachen. He is a member of council of the
German Society of Nephrology, the ERA-EDTA, the EKRA, and is a member of the
ISN and ASN. He has published widely in the field of glomerular diseases,
diabetic nephropathy, dialysis and transplantation and is a member of the
editorial board of eight journals.

M. Morales

Dr. Morales graduated from the School of Medicine at the
University of Zaragoza. He undertook postgraduate training in Madrid and Oviedo
and, since 1981, he has worked in the Nephrology Department of Hospital 12 de
Octubre in Madrid. He is presently Associate Professor of Medicine in the
University Complutense of Madrid, transplant physician of Renal Transplant
Unit, Nephrology Department. He has been a council member of ERA-EDTA, the
Spanish Society of Nephrology, and is a member of the ISN, ASN, and Spanish
Society of Immunology. His main research interests are immunosuppression in
renal transplantation, cardiovascular risk after renal transplantation,
hepatitis C, and anemia following transplantation. He has published over 300
papers in peer-review journals, organized national and international
congresses, and worked on the editorial board of several nephology journals.


Dr. Remuzzi is currently Director of the Mario Negri
Institute of Pharmacological Research in Bergamo, Italy. He graduated from the
University of Pavia in 1974, pursued postgraduate training in Milan and London
and became Director of Negri Bergamo Laboratories in 1984. He has harnessed a
diverse team of scientists studying human and experimental renal diseases
resulting in over 620 publications. Particular attention has been paid to
platelet-endothelial interactions, prostaglandin biology, progression of renal
disease, and transplant immunology and tolerance. He serves on numerous
editorial boards and currently is chairman of the Research Subcommittee of


Dr. Ronco is Professor of Clinical Nephrology and Medicine
and Director of the Department of Nephrology at St. Bortolo Hospital in
Vicenza, Italy. He graduated from University of Padua and did his internship in
Internal Medicine and Nephrology in Padua. Postgraduate training took place at
Mt. Sinai Hospital in New York, George Washington University in Washington,
D.C., and Beth Israel Medical Center in New York. His current position as
director of the Department of Nephrology in Vicenza, with his special interests
in renal replacement therapy and the program for dialytic therapy in intensive
care, cardiac surgery, and transplant surgery, is a testament to his long
commitment and research into various aspects of dialysis. Dr. Ronco has
co-authored over 508 papers, 36 book chapters, and 22 books.


Dr. Wanner did elective study in Singapore and Switzerland
before graduating from the University of Wurzburg. Training in Internal
Medicine and Nephrology took place in the Department of Medicine and Nephrology
in Freiburg. Following further study at National Institutes of Health, National
Heart, Lung and Blood Institute, Molecular Disease Branch, he became Professor
of Medicine, Department of Medicine, Division of Nephrology, University of
Wurzburg in 1994. His major research interests include the role of lipids in
progression of renal disease, diabetes, and cardiac disease in families. He is
a former president of the Kuratorium of the German Society of Nephrology, he is
a member of the ISN, ASN, and EDTA, and he serves on several editorial boards
of nephrology journals. He is the author of 90 original peer-review publications,
90 reviews and editorials, and 30 books and chapters.

G. Winearls

Dr. Winearls is currently Consultant Nephrologist and
Clinical Director, Oxford Kidney Unit, The Churchill, Oxford Radcliffe
Hospitals in Oxford, United Kingdom. He is a former member of the Executive and
Honorary Secretary of Renal Association (UK), a member of the European Renal
Association panel of Lecturers for European Nephrology Seminars, was a member
of the Organizing Committee of the International Congress of Nephrology in
London in 1987, and is an editor of the Oxford Textbook of Clinical Nephrology.
His main research interests relate to erythropoietin in renal anemia, chronic
renal disease, and polycystic kidney disease.



World Congress of Nephrology 2003: Pre-congress Meetings

Diabetes and the Kidney. 5–7 June
2003. Tel: +49 211 3382 201; Fax: +49 211 3369 103; Email:
[email protected]

ISN Forefront Meeting: Immunology in Renal Disease. 2–5 June 2003, Dross Dolln, Germany. Tel: +49
431 567 1336; Fax: +49 431 597 1337; Email: [email protected]

Congress of Nephrology 2003: Official Satellite Meetings

Glomerulonephritis and progression to renal insufficiency.
12–15 June 2003, Kloster Seeon, Bavaria,
Germany Tel: +49 89 5160 3500; Fax: +49 89 5160 4439; email:
[email protected]; website:

Kidney Transplantation in the Elderly.

12–14 June 2003, Weimar, Germany, Tel: +49 30 450 553 132; Fax: +49 30
450 553 909; email: [email protected]

End organ protection in Arterial Hypertension: beyond blood pressure control.
13 June 2003, Berlin, Germany Tel: +49 911 398
2702; Fax: +49 911 398 3183; email: [email protected]

Symposium on acute renal failure.

13–15 June 2003, Ghent, Belgium.
Tel: +32 9 240 4524; Fax: +32 9 240 4599; email:
[email protected]; website:

Advances in Renal Osteodystrophy.

13–15 June 2003, Bamberg, Germany, Tel: +49 951 503 2500; Fax: +49 951
503 2505; email: [email protected]

Stem Cells in Renal and Cardiovascular Disease.
13 June 2003, Gross-Dolln, Near Berlin, Germany email:
[email protected]

Molecular Mechanisms in Renal Disease—Ion channels and cell contact.
14 June 2003, Gross-Dolln, Near Berlin, Germany.
Tel: +49 30 9417 2202; Fax: +49 30 9417 2206; email: [email protected]

Seventh Banff Conference on Allograft Pathology.
14–18 June 2003, Aberdeen, UK. Tel: (780) 407 2607; Fax: (780)
407-2608; email: [email protected] ; website:

Immune Intervention in Nephrology—future trends.
16 June 2003, Bari, Italy. Tel: +39 80 559 2237;
Fax: +39 80 557 5710; email: [email protected]



Corporate Support of the International Society of Nephrology

President’s Circle

International Society of Nephrology is grateful to the following companies and
organizations for making a significant financial contribution to the Society in
support of achieving its goals of improving the knowledge of nephrology
worldwide and the treatment of patients with kidney disease.

Society of Nephrology



Corporate Donors

International Society of Nephrology is grateful to the following corporate,
foundation and society sponsors that have underwritten specific programs and
projects of the Society in 2002.


Pharmaceuticals, Inc.


Renal Association/ European Dialysis and Transplantation Association

Medical Care

Society of Nephrology

Brewery Company, Ltd.

& Company, Inc.

Kidney Research Fund – Great Britain

Kidney Institute



Scroll to Top